Sst2 receptor agonist octreotide inhibits release of inflammatory cytokines (TNF-α, IL-6, and IL-15) from synoviocytes of RA patients, offering a plausible mechanism for the anti-inflammatory effect of GYY4137 (Casnici et al., 2018). This evidence concerns the gene TNF and rheumatoid arthritis.